Autoimmune Diseases  >>  CD Protein Inhibitors  >>  Phase 2


Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials		 012345678910
            
            
             
Nulojix (belatacept) / BMS           
          
            
             
PF-5230895 / Emergent Biosolutions, Pfizer           
          
            
             
Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap           
          
            
             
Raptiva (efalizumab) / Roche, EMD Serono, Xoma           
          
            
             
tregalizumab (BT-061) / ADMA Biologics, T-Balance Therapeutics           
          
            
             
Rixathon (rituximab biosimilar) / Kyowa Kirin, Sandoz           
          
            
             
Amevive (alefacept) / Astellas           
          
            
             
Ruxience (rituximab-pvvr) / Pfizer           
          
            
             
TRU-015 / Pfizer           
          
            
             
Veltucyn (veltuzumab) / Gilead